RECRUITING

Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function

Talk to us

Conditions

Coronary Artery Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Older adults with coronary artery disease (CAD) have impaired vascular and inspiratory muscle function. The objective of this study is to examine the effect of beet juice supplementation on vascular and inspiratory muscle function in older adults with CAD.

Official Title

Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function

Quick Facts

Study Start:2021-11-12
Study Completion:2025-08-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04920799

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults with coronary artery disease (CAD) based on an angiogram \>50% stenosis in any major epicardial vessel or history of myocardial infarction or history of coronary revascularization.
  2. * Considered to have stable CAD on optimal medical therapy
  3. * 60 to 85 years of age
  4. * Men and women (women must be postmenopausal either natural or surgical)
  5. * Able to give consent
  1. * Ejection fraction \<50%, unstable angina, recent myocardial infarction within 6 months
  2. * Coronary revascularization, including percutaneous coronary intervention and coronary artery bypass graft or thoracic surgery within 6 months.
  3. * Stroke, obstructive pulmonary disease, hepatitis B, C, HIV, seizures, or other relevant on-going or recurrent illness
  4. * Individuals that have participated in respiratory training within the last 12 months or cardiac rehabilitation within the last 6 months
  5. * Uncontrolled hypertension
  6. * Use of tobacco products including smoking traditional or e-cigarettes
  7. * Use of hormone replacement therapy in women or men (e.g., estrogen, progesterone or testosterone)
  8. * Regular aerobic exercise training
  9. * Unwilling to stop using mouthwash at least 1 week before the start of the study and during study participation
  10. * Unwilling to remain weight stable during study participation

Contacts and Locations

Study Contact

Demetra Christou, PhD
CONTACT
352-294-1746
ddchristou@hhp.ufl.edu
Stephanie Lapierre, MS
CONTACT
ICPL@hhp.ufl.edu

Study Locations (Sites)

Integrative Cardiovascular Physiology Laboratory, University of Florida
Gainesville, Florida, 32611
United States

Collaborators and Investigators

Sponsor: University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-12
Study Completion Date2025-08-30

Study Record Updates

Study Start Date2021-11-12
Study Completion Date2025-08-30

Terms related to this study

Additional Relevant MeSH Terms

  • Coronary Artery Disease